One concern is that the highly heterogeneous complications of diabetes (e.g. diabetic retinopathy, diabetic neuropathy, diabetic cardiomyopathy, and diabetic myopathy) and their overlaying genetic architectures may lead to different discoveries regarding the association of GAS5 gene polymorphisms with advanced DKD. This evidence concerns the gene GAS5 and diabetic kidney disease.